Indomethacin therapy in premature infants of advanced postnatal age.

B. Achanti, S. Pyati, T. F. Yeh

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Indomethacin (0.3 mg/kg every eight hours IV for three doses) was administered to eight infants whose postnatal ages were eight weeks or greater and who developed patent ductus arteriosus either in the late postnatal life or in the early neonatal period but persisted. In spite of maintenance of appropriate plasma indomethacin levels, none of the infants responded with ductus closure. The present study suggests that a distinct group of infants may exist whose ductus arteriosus is prostaglandin independent and the patency of the ductus may persist.

Original languageEnglish
Pages (from-to)235-237
Number of pages3
JournalJournal of perinatology : official journal of the California Perinatal Association
Volume7
Issue number3
Publication statusPublished - Jun 1 1987
Externally publishedYes

Fingerprint

Premature Infants
Indomethacin
Ductus Arteriosus
Patent Ductus Arteriosus
Prostaglandins
Therapeutics
Maintenance

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Indomethacin therapy in premature infants of advanced postnatal age. / Achanti, B.; Pyati, S.; Yeh, T. F.

In: Journal of perinatology : official journal of the California Perinatal Association, Vol. 7, No. 3, 01.06.1987, p. 235-237.

Research output: Contribution to journalArticle

@article{ed3ab75cc6a741b39134b5190c938272,
title = "Indomethacin therapy in premature infants of advanced postnatal age.",
abstract = "Indomethacin (0.3 mg/kg every eight hours IV for three doses) was administered to eight infants whose postnatal ages were eight weeks or greater and who developed patent ductus arteriosus either in the late postnatal life or in the early neonatal period but persisted. In spite of maintenance of appropriate plasma indomethacin levels, none of the infants responded with ductus closure. The present study suggests that a distinct group of infants may exist whose ductus arteriosus is prostaglandin independent and the patency of the ductus may persist.",
author = "B. Achanti and S. Pyati and Yeh, {T. F.}",
year = "1987",
month = "6",
day = "1",
language = "English",
volume = "7",
pages = "235--237",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Indomethacin therapy in premature infants of advanced postnatal age.

AU - Achanti, B.

AU - Pyati, S.

AU - Yeh, T. F.

PY - 1987/6/1

Y1 - 1987/6/1

N2 - Indomethacin (0.3 mg/kg every eight hours IV for three doses) was administered to eight infants whose postnatal ages were eight weeks or greater and who developed patent ductus arteriosus either in the late postnatal life or in the early neonatal period but persisted. In spite of maintenance of appropriate plasma indomethacin levels, none of the infants responded with ductus closure. The present study suggests that a distinct group of infants may exist whose ductus arteriosus is prostaglandin independent and the patency of the ductus may persist.

AB - Indomethacin (0.3 mg/kg every eight hours IV for three doses) was administered to eight infants whose postnatal ages were eight weeks or greater and who developed patent ductus arteriosus either in the late postnatal life or in the early neonatal period but persisted. In spite of maintenance of appropriate plasma indomethacin levels, none of the infants responded with ductus closure. The present study suggests that a distinct group of infants may exist whose ductus arteriosus is prostaglandin independent and the patency of the ductus may persist.

UR - http://www.scopus.com/inward/record.url?scp=0023360335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023360335&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 235

EP - 237

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 3

ER -